Dapagliflozin Improves Glycemic Control and Reduces Body Weight in Patients With T2DM across the Treatment Continuum

被引:0
|
作者
Salsali, Afshin
Wei, Li
Wessman, Catrin
Hardy, Elise
Ptaszynska, Agata
Parikh, Shamik
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2353-PO
引用
收藏
页码:A593 / A594
页数:2
相关论文
共 50 条
  • [1] Adjunctive Lixisenatide Treatment Improves Glycemic Control in Patients with T2DM Irrespective of β-Cell Function
    Yabe, Daisuke
    Ambos, Anu
    Cariou, Bertrand
    Gonzalez-Galvez, Guillermo
    Ikeda, Yukio
    O'Shea, Donal
    De Pablos-Velasco, Pedro
    Smircic-Duvnjak, Lea
    Yale, Jean-Francois
    Evans, Marc
    DIABETES, 2014, 63 : A253 - A253
  • [2] Dapagliflozin—redefining treatment of T2DM?
    Edward C. Chao
    Nature Reviews Endocrinology, 2011, 7 : 696 - 697
  • [3] Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM
    Nada, Aml Mohamed
    Younan, Mariam Adel
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [4] Effect of Vildagliptin on Glycemic Control and Body Weight in Patients with T2DM Aged <45 Years: A Pooled Analysis
    Dongre, Neelesh
    Foley, James E.
    DIABETES, 2016, 65 : A578 - A578
  • [5] Genital Infections in Asian Patients with T2DM Receiving Dapagliflozin Treatment
    Ji, Linong
    Nishimura, Rimei
    Cho, Young Min
    Sjostrom, David
    Johnsson, Kristina M.
    Johnsson, Eva
    DIABETES, 2015, 64 : A658 - A658
  • [6] Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients
    Chen, Hsin-Hung
    Horng, Ming-Hwarng
    Yeh, Su-Yin
    Lin, I-Ching
    Yeh, Chih-Jung
    Muo, Chih-Hsin
    Sung, Fung-Chang
    Kao, Chia-Hung
    PLOS ONE, 2015, 10 (08):
  • [7] Colesevelam HCl improves glycemic control in patients with type 2 diabetes (T2DM): A pilot study
    Schwartz, Sherwyn L.
    Zieve, Franklin
    Kalin, Marcia
    Jones, Michael R.
    DIABETES, 2006, 55 : A134 - A134
  • [8] Bariatric Surgery and Glycemic Control in T2DM
    Fischler, Barbara
    Goodnight, Marissa
    NURSING RESEARCH, 2020, 69 (03) : E164 - E165
  • [9] DIABETES Dapagliflozin-redefining treatment of T2DM?
    Chao, Edward C.
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (12) : 696 - 697
  • [10] Canagliflozin (CANA) Improves Glycemic Control and Reduces Body Weight and Blood Pressure (BP) in Patients with Type 2 Diabetes Mellitus (T2DM) on Metformin (MET) With or Without Other Antihyperglycemic Agents (AHAs)
    Hollander, Priscilla
    Mathieu, Chantal
    Tong, Cindy
    Canovatchel, William
    Meininger, Gary
    DIABETES, 2015, 64 : A662 - A663